4.6 Review

Fulfilling the Promise of RNA Therapies for Cardiac Repair and Regeneration

Related references

Note: Only part of the references are listed.
Review Cell Biology

Long non-coding RNAs: definitions, functions, challenges and recommendations

John S. S. Mattick et al.

Summary: Genes encoding lncRNAs are abundant in complex organisms and are transcribed by RNA polymerase I, II, and III, as well as processed introns. The classification and annotation of lncRNAs are challenging due to their various functions, isoforms, and interactions with other genes. These lncRNAs evolve rapidly, are cell type-specific, and regulate multiple cellular processes, including gene expression and translation control.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2023)

Letter Biotechnology & Applied Microbiology

VEGFA mRNA for regenerative treatment of heart failure

Anna Collen et al.

NATURE REVIEWS DRUG DISCOVERY (2022)

Article Chemistry, Multidisciplinary

Delivery of modified mRNA to damaged myocardium by systemic administration of lipid nanoparticles

Martijn J. W. Evers et al.

Summary: This study evaluated the functional ability of lipid nanoparticles (LNPs) to deliver mRNA to the ischemic myocardium. The results showed that LNPs accumulated in the infarct area of the heart and delivered functional modRNA to cardiac cells. The targeted cells within the infarct area were mainly cardiac fibroblasts.

JOURNAL OF CONTROLLED RELEASE (2022)

Review Cardiac & Cardiovascular Systems

Small non-coding RNA therapeutics for cardiovascular disease

Ajay M. Shah et al.

Summary: Novel bio-therapeutic agents that utilize small, non-coding nucleic acids show great potential for clinical applications. These agents can inhibit messenger RNAs, microRNAs, or long non-coding RNAs, and offer exciting opportunities for cardiovascular diseases. Chemical modifications and carrier methods have improved the pharmacological properties and reduced immunogenicity of these therapies. There are numerous non-coding RNA therapies for cardiovascular diseases in clinical development.

EUROPEAN HEART JOURNAL (2022)

Article Cell Biology

Cardioprotective factors against myocardial infarction selected in vivo from an AAV secretome library

Giulia Ruozi et al.

Summary: Through the cardiac FunSel method, researchers have identified three proteins (Chrdl1, Fam3c, and Fam3b) that can protect cardiomyocytes from pathological remodeling and myocardial infarction. Among them, Chrdl1 exerts its protective effect by inhibiting the activity of BMP4 and TGF-beta. These findings provide new insights into the search for cardiac protective factors and potential cardiac therapies.

SCIENCE TRANSLATIONAL MEDICINE (2022)

Article Cardiac & Cardiovascular Systems

Genetic lineage tracing reveals poor angiogenic potential of cardiac endothelial cells

Tea Kocijan et al.

Summary: Cardiac ischemia does not effectively induce angiogenesis, leading to cardiomyocyte death and loss of function. Clinical trials attempting to induce therapeutic revascularization through pro-angiogenic molecule delivery have failed, indicating poor angiogenic response in cardiac endothelial cells.

CARDIOVASCULAR RESEARCH (2021)

Review Cardiac & Cardiovascular Systems

Non-coding RNA therapeutics for cardiac regeneration

Luca Braga et al.

Summary: Non-coding RNAs play crucial roles in regulating cardiac regeneration after myocardial infarction, with certain miRNAs stimulating cardiomyocyte proliferation while others suppressing it. This information has significant therapeutic implications for promoting cardiac regeneration.

CARDIOVASCULAR RESEARCH (2021)

Review Pharmacology & Pharmacy

Non-viral strategies for delivering genome editing enzymes

Jie Li et al.

Summary: Genome-editing tools like CRISPR have revolutionized various fields, but the low delivery efficiency of genome editing proteins in vivo remains a major challenge, with the most successful strategy currently involving potentially immunogenic viral vectors.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Review Pharmacology & Pharmacy

Recent advances in chemical modifications of guide RNA, mRNA and donor template for CRISPR-mediated genome editing

Qiubing Chen et al.

Summary: The discovery and applications of CRISPR systems have revolutionized nucleic acid manipulation, but face challenges in translating to therapeutic applications. Chemical modifications provide protection options, enhancing efficiency and reducing adverse effects, with remaining questions to be addressed in clinical applications.

ADVANCED DRUG DELIVERY REVIEWS (2021)

Article Multidisciplinary Sciences

The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia-reperfusion injury

Yang Zhang et al.

Summary: The study demonstrates that the long noncoding RNA lncRNA-CIRBIL is protective against ischemia-reperfusion injury by inhibiting the nuclear translocation of Bclaf1, indicating their potential as therapeutic targets for ischemic cardiac disease.

NATURE COMMUNICATIONS (2021)

Article Medicine, General & Internal

CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis

Julian D. Gillmore et al.

Summary: The gene-editing therapeutic agent NTLA-2001 effectively reduced serum TTR protein concentrations in patients with ATTR amyloidosis, showing potential safety and pharmacodynamic effects in clinical studies.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Reversible reprogramming of cardiomyocytes to a fetal state drives heart regeneration in mice

Yanpu Chen et al.

Summary: Research shows that expression of OSKM genes in adult cardiomyocytes can induce these cells to dedifferentiate, conferring regenerative capacity to the heart. This short-term dedifferentiation and reprogramming can ameliorate myocardial damage and facilitate heart regeneration.

SCIENCE (2021)

Article Cell Biology

Gene therapy knockdown of Hippo signaling induces cardiomyocyte renewal in pigs after myocardial infarction

Shijie Liu et al.

Summary: The study demonstrates the potential therapeutic value of local knockdown of the Hippo pathway gene Salvador in pig hearts using AAV9 gene therapy, leading to tissue renewal and improved function in heart failure.

SCIENCE TRANSLATIONAL MEDICINE (2021)

Article Multidisciplinary Sciences

Phospholamban antisense oligonucleotides improve cardiac function in murine cardiomyopathy

Niels Grote Beverborg et al.

Summary: The study shows that antisense inhibition of PLN is an effective therapeutic strategy in preclinical models of genetic cardiomyopathy and ischemia-driven heart failure, significantly improving cardiac function and survival rates.

NATURE COMMUNICATIONS (2021)

Article Cardiac & Cardiovascular Systems

Pkm2 Regulates Cardiomyocyte Cell Cycle and Promotes Cardiac Regeneration

Ajit Magadum et al.

CIRCULATION (2020)

Review Cardiac & Cardiovascular Systems

Gene Therapy for the Heart Lessons Learned and Future Perspectives

Antonio Cannata et al.

CIRCULATION RESEARCH (2020)

Review Cardiac & Cardiovascular Systems

Modified mRNA as a Therapeutic Tool for the Heart

Keerat Kaur et al.

CARDIOVASCULAR DRUGS AND THERAPY (2020)

Article Cardiac & Cardiovascular Systems

Transient Introduction of miR-294 in the Heart Promotes Cardiomyocyte Cell Cycle Reentry After Injury

Austin Borden et al.

CIRCULATION RESEARCH (2019)

Article Multidisciplinary Sciences

MicroRNA therapy stimulates uncontrolled cardiac repair after myocardial infarction in pigs

Khatia Gabisonia et al.

NATURE (2019)

Review Biochemistry & Molecular Biology

Past, present, and future of circRNAs

Ines Lucia Patop et al.

EMBO JOURNAL (2019)

Article Cardiac & Cardiovascular Systems

MicroRNA-124 regulates cardiomyocyte apoptosis and myocardial infarction through targeting Dhcr24

Fei Han et al.

JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY (2019)

Article Multidisciplinary Sciences

Therapeutic role of miR-19a/19b in cardiac regeneration and protection from myocardial infarction

Feng Gao et al.

NATURE COMMUNICATIONS (2019)

Article Multidisciplinary Sciences

Circular RNA CircFndc3b modulates cardiac repair after myocardial infarction via FUS/VEGF-A axis

Venkata Naga Srikanth Garikipati et al.

NATURE COMMUNICATIONS (2019)

Review Cardiac & Cardiovascular Systems

Circulating blood cells and extracellular vesicles in acute cardioprotection

Sean M. Davidson et al.

CARDIOVASCULAR RESEARCH (2019)

Article Biochemistry & Molecular Biology

miRBase: from microRNA sequences to function

Ana Kozomara et al.

NUCLEIC ACIDS RESEARCH (2019)

Review Cardiac & Cardiovascular Systems

Cell therapy trials for heart regeneration - lessons learned and future directions

Philippe Menasche

NATURE REVIEWS CARDIOLOGY (2018)

Review Genetics & Heredity

Towards a complete map of the human long non-coding RNA transcriptome

Barbara Uszczynska-Ratajczak et al.

NATURE REVIEWS GENETICS (2018)

Article Medicine, General & Internal

Patisiran, an RNAi Therapeutic, for Hereditary Transthyretin Amyloidosis

D. Adams et al.

NEW ENGLAND JOURNAL OF MEDICINE (2018)

Review Biochemistry & Molecular Biology

Lipid Nanoparticles Enabling Gene Therapies: From Concepts to Clinical Utility

Jayesh A. Kulkarni et al.

NUCLEIC ACID THERAPEUTICS (2018)

Review Biochemistry & Molecular Biology

GalNAc-siRNA Conjugates: Leading the Way for Delivery of RNAi Therapeutics

Aaron D. Springer et al.

NUCLEIC ACID THERAPEUTICS (2018)

Article Medicine, Research & Experimental

Gene Therapy via Trans-Splicing for LMNA-Related Congenital Muscular Dystrophy

Feriel Azibani et al.

MOLECULAR THERAPY-NUCLEIC ACIDS (2018)

Article Medicine, Research & Experimental

Biocompatible, Purified VEGF-A mRNA Improves Cardiac Function after Intracardiac Injection 1 Week Post-myocardial Infarction in Swine

Leif Carlsson et al.

MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)

Article Biotechnology & Applied Microbiology

Cellular uptake and trafficking of antisense oligonucleotides

Stanley T. Crooke et al.

NATURE BIOTECHNOLOGY (2017)

Article Medicine, Research & Experimental

Neonatal Heart-Enriched miR-708 Promotes Proliferation and Stress Resistance of Cardiomyocytes in Rodents

Shengqiong Deng et al.

THERANOSTICS (2017)

Article Cardiac & Cardiovascular Systems

Single-Dose Intracardiac Injection of Pro-Regenerative MicroRNAs Improves Cardiac Function After Myocardial Infarction

Pierluigi Lesizza et al.

CIRCULATION RESEARCH (2017)

Review Medical Laboratory Technology

Gene transfer to promote cardiac regeneration

Chiara Collesi et al.

CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES (2016)

Article Medicine, Research & Experimental

Antisense-mediated exon skipping: a therapeutic strategy for titin-based dilated cardiomyopathy

Michael Gramlich et al.

EMBO MOLECULAR MEDICINE (2015)

Review Biotechnology & Applied Microbiology

mRNA-based therapeutics - developing a new class of drugs

Ugur Sahin et al.

NATURE REVIEWS DRUG DISCOVERY (2014)

Article Cardiac & Cardiovascular Systems

Inhibition of MicroRNA-92a Protects Against Ischemia/Reperfusion Injury in a Large-Animal Model

Rabea Hinkel et al.

CIRCULATION (2013)

Article Multidisciplinary Sciences

MicroRNA-34a regulates cardiac ageing and function

Reinier A. Boon et al.

NATURE (2013)

Article Biotechnology & Applied Microbiology

Modified mRNA directs the fate of heart progenitor cells and induces vascular regeneration after myocardial infarction

Lior Zangi et al.

NATURE BIOTECHNOLOGY (2013)

Review Biotechnology & Applied Microbiology

Current Stem Cell Delivery Methods for Myocardial Repair

Calvin C. Sheng et al.

BIOMED RESEARCH INTERNATIONAL (2013)

Article Cardiac & Cardiovascular Systems

Long-Term miR-669a Therapy Alleviates Chronic Dilated Cardiomyopathy in Dystrophic Mice

Mattia Quattrocelli et al.

JOURNAL OF THE AMERICAN HEART ASSOCIATION (2013)

Editorial Material Cardiac & Cardiovascular Systems

The myocardial area at risk

Carlos Eduardo Rochitte et al.

HEART (2012)

Article Multidisciplinary Sciences

Heart repair by reprogramming non-myocytes with cardiac transcription factors

Kunhua Song et al.

NATURE (2012)

Article Multidisciplinary Sciences

Functional screening identifies miRNAs inducing cardiac regeneration

Ana Eulalio et al.

NATURE (2012)

Review Biotechnology & Applied Microbiology

MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles

Eva van Rooij et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Review Biochemistry & Molecular Biology

Chemical modification and design of anti-miRNA oligonucleotides

K. A. Lennox et al.

GENE THERAPY (2011)

Article Multidisciplinary Sciences

Primary contribution to zebrafish heart regeneration by gata4+ cardiomyocytes

Kazu Kikuchi et al.

NATURE (2010)

Article Biochemistry & Molecular Biology

Non-redundant functions of the protein isoforms arising from alternative splicing of the VEGF-A pre-mRNA

Mauro Giacca

TRANSCRIPTION-AUSTIN (2010)

Article Biotechnology & Applied Microbiology

In vivo imaging shows abnormal function of vascular endothelial growth factor-induced vasculature

Serena Zacchigna et al.

HUMAN GENE THERAPY (2007)

Review Cardiac & Cardiovascular Systems

Regeneration gaps - Observations on stem cells and cardiac repair

CE Murry et al.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)

Article Chemistry, Multidisciplinary

Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids

J Heyes et al.

JOURNAL OF CONTROLLED RELEASE (2005)